GSK plc
This senior leadership role focuses on end-to-end translational science within renal, inflammation, fibrosis, and neurodegeneration areas. It involves developing disease biomarker strategies to inform clinical development decisions, validating novel technologies like spatial transcriptomics, and leading cross-functional collaborations across research, clinical, and business teams. The position requires establishing external partnerships with academic institutions and CROs to enhance human translation and predictive value for drug progression.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
14% above the average for this role
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Director, Molecular Pathology, Translational Sciences, Translational Research.
Revolution Medicines
Associate Director, Global Biomarker Lead, Inflammation, GI2 TAU
BioLife Plasma Services
Senior Principal Scientist, Neuroscience, Clinical Biomarker, Late Phases, Translational Medicine
Bristol Myers Squibb
Sr Scientist, Biomarkers & Translational Inflammation
Gilead Sciences
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Principal Scientist - Cell Therapy Translational Research
Bristol Myers Squibb